Mary J. Ortner
Algemeen Directeur bij Biophagy, Inc.
Profiel
Mary J.
Ortner is currently the President & Chief Executive Officer at Biophagy, Inc. Previously, she worked as the Chief Business Officer at SolaranRx, Inc. Dr. Ortner holds a graduate degree from California State University-Los Angeles, an MBA from the University of Connecticut, and a doctorate from the University of Hawai'i at Hilo.
Actieve functies van Mary J. Ortner
| Bedrijven | Functie | Begin |
|---|---|---|
Biophagy, Inc.
 Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner. | Algemeen Directeur | - |
Eerdere bekende functies van Mary J. Ortner
| Bedrijven | Functie | Einde |
|---|---|---|
SolaranRx, Inc.
 SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Corporate Officer/Principal | - |
Opleiding van Mary J. Ortner
| University of Hawai'i at Hilo | Doctorate Degree |
| California State University-Los Angeles | Graduate Degree |
| University of Connecticut | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SolaranRx, Inc.
SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Health Technology |
Biophagy, Inc.
Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner. | Health Technology |
